The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-(4-((4-(1H-Pyrazol-4-yl)phenyl)amino)-6-methyl-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-yl)phenoxy)-N-(pentan-3-yl)acetamide ID: ALA4647586
PubChem CID: 124159247
Max Phase: Preclinical
Molecular Formula: C30H35N7O2
Molecular Weight: 525.66
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CCC(CC)NC(=O)COc1cccc(-c2nc3c(c(Nc4ccc(-c5cn[nH]c5)cc4)n2)CN(C)CC3)c1
Standard InChI: InChI=1S/C30H35N7O2/c1-4-23(5-2)33-28(38)19-39-25-8-6-7-21(15-25)29-35-27-13-14-37(3)18-26(27)30(36-29)34-24-11-9-20(10-12-24)22-16-31-32-17-22/h6-12,15-17,23H,4-5,13-14,18-19H2,1-3H3,(H,31,32)(H,33,38)(H,34,35,36)
Standard InChI Key: VXKAOEFNKQZVOS-UHFFFAOYSA-N
Molfile:
RDKit 2D
39 43 0 0 0 0 0 0 0 0999 V2000
30.4917 -6.0243 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.2055 -5.6107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2027 -4.7839 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.4899 -4.3787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4875 -3.5574 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.1981 -3.1425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9049 -3.5555 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6150 -3.1414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6130 -2.3192 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8950 -1.9129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1919 -2.3252 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3175 -1.9092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0696 -2.2383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6180 -1.6245 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.2022 -0.9144 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3995 -1.0920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9103 -6.0216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9103 -6.8440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6219 -7.2514 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3341 -6.8417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3302 -6.0161 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6179 -5.6083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.0399 -5.5998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.7538 -6.0089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4636 -5.5926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4594 -4.7713 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.1775 -6.0017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.8872 -5.5854 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7795 -5.6112 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7836 -4.7920 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0801 -4.3812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.3681 -4.7850 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
28.3640 -5.6041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0720 -6.0195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5977 -5.9891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8816 -4.7682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5864 -4.3547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3026 -5.5756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.6630 -4.3719 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29 1 1 0
1 2 2 0
2 3 1 0
3 4 2 0
4 30 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 12 2 0
9 12 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
2 17 1 0
21 23 1 0
23 24 1 0
24 25 1 0
25 26 2 0
25 27 1 0
27 28 1 0
29 30 2 0
29 34 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
28 35 1 0
28 36 1 0
36 37 1 0
35 38 1 0
32 39 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 525.66Molecular Weight (Monoisotopic): 525.2852AlogP: 4.95#Rotatable Bonds: 10Polar Surface Area: 108.06Molecular Species: NEUTRALHBA: 7HBD: 3#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 3#RO5 Violations (Lipinski): 1CX Acidic pKa: 13.84CX Basic pKa: 6.94CX LogP: 4.85CX LogD: 4.72Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.27Np Likeness Score: -1.52
References 1. Liu KG, Kim JI, Olszewski K, Barsotti AM, Morris K, Lamarque C, Yu X, Gaffney J, Feng XJ, Patel JP, Poyurovsky MV.. (2020) Discovery and Optimization of Glucose Uptake Inhibitors., 63 (10): [PMID:32282207 ] [10.1021/acs.jmedchem.9b02153 ]